Combined aclidinium bromide and long‐acting beta2‐agonist for chronic obstructive pulmonary disease (COPD)
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Combined Aclidinium Bromide and Long‐acting Beta2‐agonist for Chronic Obstructive Pulmonary Disease (COPD)." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435321/all/Combined_aclidinium_bromide_and_long‐acting_beta2‐agonist_for_chronic_obstructive_pulmonary_disease__COPD_.
Combined aclidinium bromide and long‐acting beta2‐agonist for chronic obstructive pulmonary disease (COPD). Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435321/all/Combined_aclidinium_bromide_and_long‐acting_beta2‐agonist_for_chronic_obstructive_pulmonary_disease__COPD_. Accessed February 13, 2025.
Combined aclidinium bromide and long‐acting beta2‐agonist for chronic obstructive pulmonary disease (COPD). (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435321/all/Combined_aclidinium_bromide_and_long‐acting_beta2‐agonist_for_chronic_obstructive_pulmonary_disease__COPD_
Combined Aclidinium Bromide and Long‐acting Beta2‐agonist for Chronic Obstructive Pulmonary Disease (COPD) [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 February 13]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435321/all/Combined_aclidinium_bromide_and_long‐acting_beta2‐agonist_for_chronic_obstructive_pulmonary_disease__COPD_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Combined aclidinium bromide and long‐acting beta2‐agonist for chronic obstructive pulmonary disease (COPD)
ID - 435321
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435321/all/Combined_aclidinium_bromide_and_long‐acting_beta2‐agonist_for_chronic_obstructive_pulmonary_disease__COPD_
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -